NATIVE COMPLEX PLATFORM Trademark

Trademark Overview


On Thursday, February 15, 2024, a trademark application was filed for NATIVE COMPLEX PLATFORM with the United States Patent and Trademark Office. The USPTO has given the NATIVE COMPLEX PLATFORM trademark a serial number of 98406551. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, September 20, 2024. This trademark is owned by Septerna, Inc.. The NATIVE COMPLEX PLATFORM trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing a website featuring information about the treatment and/or diagnosis of neurological disorders, endocrine disorders, metabolic disorders, autoimmune diseases and immunological disorders, cancer, cardiovascular disorders, gastrointestinal disorders, pain, ophthalmic disorders, psychiatric disorders, respiratory disorders, urologic and reproductive disorders, and musculoskeletal disorders

Bio-technology and scientific services, namely, research, and production and development services relating to bio-technology and science, namely, G-protein coupled receptors (GPCRs), GPCR ligands, GPCR transducer proteins, and GPCR interacting proteins; pharmaceutical research and development; Scientific and technological services, namely, biological and bio-technology analysis services; scientific and medical laboratory services; biochemistry research services, namely, treating therapeutic targets through chemical and biochemical preparations
native complex platform

General Information


Serial Number98406551
Word MarkNATIVE COMPLEX PLATFORM
Filing DateThursday, February 15, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, September 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding a website featuring information about the treatment and/or diagnosis of neurological disorders, endocrine disorders, metabolic disorders, autoimmune diseases and immunological disorders, cancer, cardiovascular disorders, gastrointestinal disorders, pain, ophthalmic disorders, psychiatric disorders, respiratory disorders, urologic and reproductive disorders, and musculoskeletal disorders
Goods and ServicesBio-technology and scientific services, namely, research, and production and development services relating to bio-technology and science, namely, G-protein coupled receptors (GPCRs), GPCR ligands, GPCR transducer proteins, and GPCR interacting proteins; pharmaceutical research and development; Scientific and technological services, namely, biological and bio-technology analysis services; scientific and medical laboratory services; biochemistry research services, namely, treating therapeutic targets through chemical and biochemical preparations

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 15, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 15, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSepterna, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94080

Trademark Events


Event DateEvent Description
Thursday, February 15, 2024NEW APPLICATION ENTERED
Monday, June 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 7, 2024ASSIGNED TO EXAMINER
Friday, September 20, 2024NON-FINAL ACTION WRITTEN
Friday, September 20, 2024NON-FINAL ACTION E-MAILED
Friday, September 20, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED